Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale.

Autor:	Jagota P; Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Srivanitchapoom P; Neurology Division, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Petchrutchatachart S; Department of Neurology, Phyathai 1 Hospital, Bangkok, Thailand., Singmaneesakulchai S; Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Pisarnpong A; Neurology Division, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Brain Center, Bangkok Hospital, Bangkok, Thailand., Lolekha P; Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand., Setthawatcharawanich S; Department of Medicine, Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Chairangsaris P; Neurology division, Phramongkutklao Hospital, Bangkok, Thailand., Limotai N; Department of Neurology, Neurological Institute of Thailand, Bangkok, Thailand., Mekawichai P; Neurology Unit, Department of Medicine, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand., Panyakaew P; Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Phokaewvarangkul O; Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Sringean J; Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Pitakpatapee Y; Neurology Division, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., LaPelle N; University of Massachusetts Medical School, Preventive and Behavioral Medicine, Worchester, MA, USA., Martinez-Martin P; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain., Ren X; Department of Biostatistics, Gilead Sciences Inc., Foster City, CA, USA., Luo S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Stebbins GT; Rush University Medical Center, Neurological Sciences, Chicago, IL, USA., Goetz CG; Rush University Medical Center, Neurological Sciences, Chicago, IL, USA., Bhidayasiri R; Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.; The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
Jazyk:	angličtina
Zdroj:	Journal of movement disorders [J Mov Disord] 2022 May; Vol. 15 (2), pp. 151-155. Date of Electronic Publication: 2022 Mar 16.
DOI:	10.14802/jmd.21104
Abstrakt:	Objective: This study aims to validate the Thai translation of the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Methods: The English version was translated into Thai and then back-translated into English. The translated version underwent 2 rounds of cognitive pretesting to assess the ease of comprehension, ease of use and comfort with the scale. Then, it underwent large clinimetric testing. Results: The Thai version was validated in 354 PD patients. The comparative fit index (CFI) for all four parts of the Thai version of the MDS-UPDRS was 0.93 or greater. Exploratory factor analysis identified isolated item differences in factor structure between the Thai and English versions. Conclusion: The overall factor structure of the Thai version was consistent with that of the English version based on the high CFIs (all CFI ≥ 0.90). Hence, it can be designated the official Thai version of the MDS-UPDRS.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu